Your browser is no longer supported. Please, upgrade your browser.
Settings
MRK Merck & Co., Inc. daily Stock Chart
MRK [NYSE]
Merck & Co., Inc.
IndexDJIA S&P500 P/E18.60 EPS (ttm)3.86 Insider Own0.10% Shs Outstand2.57B Perf Week0.52%
Market Cap184.24B Forward P/E11.41 EPS next Y6.29 Insider Trans-3.82% Shs Float2.53B Perf Month-8.13%
Income9.96B PEG2.27 EPS next Q1.35 Inst Own78.20% Short Float0.82% Perf Quarter-21.47%
Sales46.84B P/S3.93 EPS this Y58.90% Inst Trans0.20% Short Ratio1.57 Perf Half Y-14.48%
Book/sh10.18 P/B7.05 EPS next Y9.94% ROA11.80% Target Price97.67 Perf Year-13.19%
Cash/sh4.07 P/C17.63 EPS next 5Y8.18% ROE36.50% 52W Range65.25 - 92.64 Perf YTD-21.13%
Dividend2.44 P/FCF43.13 EPS past 5Y-1.10% ROI19.20% 52W High-22.57% Beta0.58
Dividend %3.40% Quick Ratio1.00 Sales past 5Y2.10% Gross Margin71.90% 52W Low9.93% ATR4.18
Employees71000 Current Ratio1.20 Sales Q/Q7.90% Oper. Margin24.80% RSI (14)43.63 Volatility6.20% 5.92%
OptionableYes Debt/Eq1.02 EPS Q/Q17.00% Profit Margin21.00% Rel Volume0.89 Prev Close73.53
ShortableYes LT Debt/Eq0.88 EarningsFeb 05 BMO Payout58.90% Avg Volume13.23M Price71.73
Recom1.90 SMA20-5.03% SMA50-11.88% SMA200-14.91% Volume11,725,842 Change-2.45%
Feb-27-20Initiated Barclays Overweight $93
Jan-07-20Initiated RBC Capital Mkts Sector Perform $99
Oct-17-19Resumed BofA/Merrill Neutral $90
Aug-16-19Initiated SVB Leerink Outperform
Jul-03-19Initiated Mizuho Buy $97
May-28-19Initiated Goldman Neutral
May-13-19Upgrade Atlantic Equities Neutral → Overweight
Oct-16-18Reiterated Citigroup Buy $70 → $79
Oct-09-18Resumed Guggenheim Buy
Apr-23-18Upgrade Goldman Neutral → Buy
Apr-17-18Upgrade Morgan Stanley Equal-Weight → Overweight
Apr-05-18Upgrade Barclays Equal Weight → Overweight $62 → $64
Mar-12-18Upgrade Leerink Partners Mkt Perform → Outperform
Feb-14-18Reiterated Leerink Partners Mkt Perform $67 → $66
Feb-07-18Reiterated Morgan Stanley Equal-Weight $60 → $63
Jan-16-18Upgrade SunTrust Hold → Buy
Nov-28-17Resumed BofA/Merrill Buy $64
Nov-24-17Reiterated Deutsche Bank Hold $62 → $59
Oct-31-17Upgrade Jefferies Underperform → Hold
Oct-30-17Downgrade SunTrust Buy → Hold
Mar-26-20 09:20AM  $110M injection powers up Peninsula vaccine maker but not for COVID-19 American City Business Journals +7.78%
Mar-25-20 06:57PM  J&J's Chief Scientific Officer predicts vaccinations against coronavirus within 12 months Yahoo Finance
05:00PM  Merck to Donate 300,000 Masks to New Jersey for COVID-19 Emergency Response Business Wire
11:48AM  UPS Seeks To Accelerate Growth Of Drone-Delivery Benzinga
Mar-23-20 09:15AM  The Zacks Analyst Blog Highlights: Pfizer, Roche, Sanofi, Lilly and Merck Zacks -6.95%
Mar-22-20 11:52AM  Merck Donates a Half a Million Masks to Support COVID-19 Emergency Response in New York City Business Wire
Mar-21-20 11:19AM  Market Experts Say the Coronavirus Selloff Is Worse Than Anything Weve Seen Since 1929. Heres How Bad It Could Get. Barrons.com
Mar-20-20 05:01PM  Merck Recommends Rejection of TRC Capitals "Mini-Tender" Offer Business Wire
10:52AM  Pharma Stock Roundup: SNY, RHHBY, PFE's Coronavirus Product Development & Other Updates Zacks
06:13AM  Maryland biotech CEO: Virus outbreak won't stop opening of Boston R&D hub American City Business Journals
Mar-17-20 04:41PM  Markets Are in Free Fall, but Don't Give in to Panic GuruFocus.com +6.52%
08:48AM  The Daily Biotech Pulse: Setback For DBV In Peanut Allergy Patch Review, Roche Starts Coronavirus Test Shipment, Regeneron Aims For 'Cocktail' COVID-19 Treatment Benzinga
06:45AM  Merck Announces Top-Line Results from Phase 3 Trials Evaluating Gefapixant, an Investigational Treatment for Refractory or Unexplained Chronic Cough Business Wire
Mar-13-20 04:11PM  AstraZeneca/Merck's Lynparza Combo Ovarian Cancer Study Fails Zacks
Mar-12-20 03:00AM  Update on Phase 3 GY004 for Cediranib and LYNPARZA® (olaparib) in Platinum-Sensitive Relapsed Ovarian Cancer Business Wire -6.06%
Mar-09-20 03:19PM  Eli Lilly and 2 More Drug Stocks That Could Ride Out the Coronavirus Crisis, According to J.P. Morgan Barrons.com
03:04PM  Merck tells Montco employees to work from home amid coronavirus concerns American City Business Journals
Mar-08-20 01:10PM  Merck & Co., Inc. (MRK): Are Hedge Funds Right About This Stock? Insider Monkey
09:32AM  Why It Might Not Make Sense To Buy Merck & Co., Inc. (NYSE:MRK) For Its Upcoming Dividend Simply Wall St.
Mar-04-20 02:33PM  Biopharma companies race to create coronavirus vaccine Yahoo Finance Video
08:01AM  Redefining Cancer Treatment Shines Light on Cancer Immunotherapies CNW Group
06:45AM  Scientists from Merck and the Walter and Eliza Hall Institute of Medical Research Discover Novel Class of Candidate Anti Malaria Agents that Block Multiple Stages of the Lifecycle of the Parasite Business Wire
Mar-02-20 05:59PM  US Indexes Close Higher Monday GuruFocus.com +6.28%
03:01PM  Stocks Are Snapping Back as Investors Bet on the Fed Barrons.com
02:57PM  Apple Inc., Walmart share gains contribute to Dow's nearly 600-point surge MarketWatch
01:52PM  Dow's 650-point surge highlighted by gains in Apple Inc., Walmart shares MarketWatch
12:46PM  Walmart, Apple Inc. share gains contribute to Dow's 750-point surge MarketWatch
11:45AM  Walmart, Apple Inc. share gains lead Dow's nearly 625-point surge MarketWatch
10:45AM  Dow's 325-point rally led by gains for Walmart, Merck stocks MarketWatch
07:02AM  Takeda, Merck invest in Waltham cancer startup's $100M round American City Business Journals
06:45AM  Merck Announces New Data from Broad HIV Program at CROI 2020 Business Wire
06:30AM  Mercks KEYTRUDA® (pembrolizumab) Significantly Improved Progression-Free Survival Compared with Brentuximab Vedotin in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma (cHL) Business Wire
Feb-28-20 06:46PM  How the Coronavirus Will Challenge the Health-Care Industry Barrons.com
09:07AM  FDA Reports First Drug Shortage Due to Coronavirus, Far Earlier Than Expected Barrons.com
Feb-27-20 03:04PM  Why coronavirus is a 'shock' to global economy NC State economist weighs in American City Business Journals
09:54AM  New bill aims to protect medical product supply chain amid coronavirus outbreak Yahoo Finance Video
06:45AM  Merck to Present at the Cowen Health Care Conference Business Wire
Feb-26-20 12:27PM  Coronavirus fears sparks market swings Yahoo Finance Video
Feb-25-20 04:57PM  Peter Thiels Palantir Wins Role in $823 Million Government Contract Bloomberg
03:20PM  Moderna soars on vaccine progress for coronavirus Yahoo Finance Video
Feb-22-20 01:00PM  Benzinga's Bulls And Bears Of The Week: Merck, Nike, Target And More Benzinga
Feb-21-20 02:36PM  Triad university to dedicate business college in honor of donor, alumni American City Business Journals
10:03AM  Pharma Stock Roundup: AZN Reports Q4 Results, NVS, PFE Drugs Get EU Approval Zacks
Feb-20-20 04:51PM  4 Most Popular Healthcare Stocks Among Hedge Funds: Q4 Rankings Insider Monkey
Feb-19-20 09:51AM  Jim Simons: The Investing Guru Bets on These 3 Healthcare Stocks TipRanks
Feb-18-20 07:17PM  Merck Receives Complete Response Letter from the US FDA for Supplemental Biologics License Applications (sBLAs) for KEYTRUDA® (pembrolizumab) Six-Week Dosing Schedule Business Wire
Feb-14-20 11:20AM  ERVEBO® (Ebola Zaire Vaccine, Live) Now Registered in Four African Countries, Within 90 Days of Reference Country Approval and WHO Prequalification Business Wire
Feb-13-20 02:25PM  3 Dow Jones Industrial Average Stocks to Sell InvestorPlace
Feb-12-20 05:55PM  Richard Pzena Trims Walmart, Merck Positions GuruFocus.com
02:54PM  Merck Shares Slip In Favor of a Peer, Evercore ISI Says Bloomberg
06:45AM  Mercks KEYTRUDA® (pembrolizumab) in Combination with Chemotherapy Met Primary Endpoint of Progression-Free Survival (PFS) as First-Line Treatment for Metastatic Triple-Negative Breast Cancer (mTNBC) Business Wire
Feb-11-20 03:11PM  Ethics in Stock Picking GuruFocus.com
07:23AM  The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology Benzinga
Feb-10-20 05:54AM  This once-faltering cancer startup just raised $117M. Heres how it plans to spend it. American City Business Journals
Feb-09-20 03:22PM  The Week Ahead In Biotech: SMID-Cap Earnings In The Spotlight Benzinga
09:38AM  Merck & Co., Inc. Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock? Simply Wall St.
Feb-07-20 04:57PM  An Experts Advice for Cutting Your Tax Bill Barrons.com
03:07PM  How Big a Hit? Health-Care Companies Try to Gauge the Costs of Coronavirus. Barrons.com
12:32PM  What to expect from new Merck spinoff, according to the CEO American City Business Journals
11:15AM  Seattle Genetics (SGEN) Q4 Earnings Top, Adcetris Drives Sales Zacks
10:24AM  Pharma Stock Roundup: BMY, GSK, SNY Q4 Results, MRK Earnings & Split Zacks
Feb-06-20 05:36PM  J&J Brand Most Valuable Among Pharmaceutical Companies GuruFocus.com
03:48PM  Merck Will No Longer Be Easy to Own on Keytruda Dominance Bloomberg
03:45PM  Bristol-Myers' (BMY) Q4 Earnings & Revenues Beat Estimates Zacks
11:45AM  Why Merck (MRK) is a Great Dividend Stock Right Now Zacks
09:49AM  US Indexes Close Higher With Impeachment Acquittal GuruFocus.com
06:59AM  Bristol-Myers earnings rise due to Celgene deal Reuters
05:12AM  Merck Sharp & Dohme Corp. -- Moody's affirms Merck's A1/Prime-1 ratings; stable outlook Moody's
05:01AM  Why Merck Is Spinning Off 3 Divisions, and Two More Numbers to Know Barrons.com
02:01AM  PRESS DIGEST -Wall Street Journal - Feb 6 Reuters
01:17AM  Edited Transcript of MRK earnings conference call or presentation 5-Feb-20 1:00pm GMT Thomson Reuters StreetEvents
Feb-05-20 06:02PM  Merck Shares Drop After Spinoff Announced GuruFocus.com
04:22PM  US STOCKS-S&P 500, Nasdaq mint record highs after strong U.S. data, waning virus fears Reuters
03:02PM  US STOCKS-Wall St gains after strong US data, waning virus fears; Tesla limits Nasdaq's rise Reuters
12:07PM  Strong Private Sector Payrolls in January Zacks
11:42AM  Merck & Co., Inc. -- Moody's affirms Merck's A1/Prime-1 ratings; stable outlook Moody's
10:42AM  ADP Posts Blowout +291K New Jobs for January Zacks
09:47AM  Merck (MRK) Beats on Q4 Earnings, Plans Women Health Spin Off Zacks
09:46AM  Dow tries for a 3rd day of gains amid upbeat data, hope of coronavirus treatments MarketWatch
09:36AM  Merck Tops Q4 Profit Forecast, Plans Womens' Health, Biosimilars Spinoff TheStreet.com
09:26AM  Merck to streamline business, separate into two companies American City Business Journals
09:22AM  Merck Is Spinning Off 3 Divisions to Focus on Key Growth Drivers, CEO Ken Frazier Said Barrons.com
09:15AM  Stocks - GM Rises in Premarket; Merck Falls on Spin-Off News Investing.com
09:11AM  Merck's stock is the only Dow member losing ground, after earnings and spinoff news MarketWatch
08:42AM  Ford Motor Stock, Snap Are Sliding, but Hope About Coronavirus Is Lifting the Dow Barrons.com
07:40AM  Merck to spin off assets in bid to streamline its business Financial Times
07:05AM  Merck announces spinoffs, reports profit beat but sales miss; stock falls MarketWatch
06:53AM  Merck to spin-off women's health, biosimilar businesses Reuters
06:47AM  Merck Announces Fourth-Quarter and Full-Year 2019 Financial Results Business Wire
06:45AM  Merck to Focus on Key Growth Pillars Through Spinoff of Womens Health, Trusted Legacy Brands and Biosimilars Products into New Company ("NewCo") Business Wire
06:00AM  Merck & Co., Inc. to Host Earnings Call ACCESSWIRE
01:49AM  Merck&Co Earnings Beat, Revenue Misses In Q4 Investing.com
Feb-04-20 04:15PM  Merck's Keytruda: How Long Can It Fend Off Cancer-Treatment Rivals? Investor's Business Daily
12:39PM  Day Ahead: Top 3 Things to Watch for Feb. 5 Investing.com
12:08PM  Merck's Keytruda: How Long Can It Fend Off Cancer-Treatment Rivals? Investor's Business Daily
10:32AM  Should You Buy Merck (MRK) Ahead of Earnings? Zacks
10:24AM  Merck's Recarbrio Gets FDA Priority Review for New Indication Zacks
10:13AM  Will Opdivo & Eliquis Drive Bristol-Myers (BMY) Q4 Earnings? Zacks
09:49AM  US Indexes End Higher Monday to Start February GuruFocus.com
08:03AM  AbbVie (ABBV) to Report Q4 Earnings: What's in the Cards? Zacks
Merck & Co., Inc. provides healthcare solutions worldwide. It operates through Pharmaceutical and Animal Health segments. The company offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, chronic hepatitis C virus, HIV-1 infection, intra-abdominal, fungal infection, insomnia, and inflammatory diseases; neuromuscular blocking agents; cholesterol modifying medicines; and anti-bacterial and vaginal contraceptive products. It also provides products to prevent chemotherapy-induced and post-operative nausea and vomiting; treat non-small-cell lung, ovarian and breast, esophageal, thyroid, cervical, and brain cancers; and prevent diseases caused by human papillomavirus, as well as vaccines for measles, mumps, rubella, varicella, shingles, rotavirus gastroenteritis, and pneumococcal diseases. In addition, the company offers drugs for hepatocellular and merkel cell carcinoma; antibiotic and anti-inflammatory drugs to treat infectious and respiratory diseases, fertility disorders, and pneumonia in cattle, bovine, and swine; vaccines for poultry; parasiticides for sea lice in salmon; and antibiotics and vaccines for fish. Further, it provides companion animal products; diabetes mellitus treatment and anthelmintic products for dogs and cats; products to treat fleas, ticks, mosquitoes, and sandflies; horse fertility management products for swine; and dog, cat, and horse vaccines. Additionally, the company offers services and solutions that focus on engagement, clinical, and health analytics. Merck & Co., Inc. primarily has collaborations with AstraZeneca PLC; Bayer AG; and Eisai Co., Ltd. It serves drug wholesalers and retailers, hospitals, and government agencies, as well as managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; physicians and physician distributors, veterinarians, and animal producers. The company was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gerberding Julie L.EVP Strat Comm, GI Pub PolicyJan 13Option Exercise0.0082,5480139,111Jan 15 05:15 PM
Gerberding Julie L.EVP Strat Comm, GI Pub PolicyJan 13Sale89.34102,0739,118,86537,038Jan 15 05:15 PM
Nally MichaelEVP, Chief Marketing OfficerOct 30Option Exercise0.002,28706,196Nov 01 05:07 PM
MIZELL STEVENEVP, Chief HR OfficerOct 30Option Exercise0.004,57404,574Nov 01 05:07 PM
Clyburn FrankEVP, Chief Commercial OfficerOct 30Option Exercise0.002,287073,032Nov 01 05:06 PM
Scholefield James HEVP,Chief Info&Digital OfficerOct 30Option Exercise0.0011,436011,436Nov 01 05:04 PM
DeLuca Richard R.EVP&Pres, Merck Animal HeallthAug 09Option Exercise0.006,427077,951Aug 12 05:13 PM
DeLuca Richard R.EVP&Pres, Merck Animal HeallthAug 09Sale85.096,427546,85071,524Aug 12 05:13 PM
DeLuca Richard R.EVP&Pres, Merck Animal HeallthAug 08Option Exercise0.0031,6990103,223Aug 12 05:13 PM
DeLuca Richard R.EVP&Pres, Merck Animal HeallthAug 08Sale85.0131,6992,694,78971,524Aug 12 05:13 PM
Davis Robert MEVP, Global Svcs & CFOJun 25Option Exercise0.00216,7180354,378Jun 27 05:05 PM
Davis Robert MEVP, Global Svcs & CFOJun 25Sale85.43216,71818,514,032137,660Jun 27 05:05 PM
Karachun Rita ASr. VP Fince-Global ControllerMay 10Option Exercise0.003,292022,412May 13 05:06 PM
Clyburn FrankEVP, Chief Commercial OfficerMay 10Option Exercise0.004,389071,993May 13 05:05 PM
Fleming MichaelSVP Chief Ethics & Com OfficerMay 10Option Exercise0.001,50903,317May 13 05:05 PM
Nally MichaelEVP, Chief Marketing OfficerMay 10Option Exercise0.001,81104,376May 13 05:06 PM
Clyburn FrankEVP, Chief Commercial OfficerMay 07Option Exercise39.2925,000982,25092,604May 09 06:11 PM
Clyburn FrankEVP, Chief Commercial OfficerMay 07Sale77.7325,0001,943,18367,604May 09 06:11 PM
Karachun Rita ASr. VP Fince-Global ControllerMay 04Option Exercise0.001,212019,717May 07 08:32 PM
Fleming MichaelSVP Chief Ethics & Com OfficerMay 04Option Exercise0.0069202,046May 07 08:32 PM
Zachary JenniferEVP, General CounselMay 04Option Exercise0.005,77205,772May 07 07:42 PM
Nally MichaelEVP, Chief Marketing OfficerMay 04Option Exercise0.001,29802,935May 07 07:40 PM
Clyburn FrankEVP, Chief Commercial OfficerMay 04Option Exercise0.001,904068,542May 07 07:37 PM
DeLuca Richard R.EVP&Pres, Merck Animal HeallthMay 03Option Exercise39.2935,0001,375,150106,064May 07 08:33 PM
DeLuca Richard R.EVP&Pres, Merck Animal HeallthMay 03Sale80.0035,0002,800,00071,064May 07 08:33 PM
Merck & Co., Inc.10% OwnerApr 08Buy16.004,121,68365,946,92812,955,016Apr 09 06:27 PM